1. Home
  2. TVGN

as of 12-12-2025 11:28am EST

$0.40
$0.03
-7.06%
Stocks Finance Blank Checks Nasdaq

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Chart Type:
Time Range:
Founded: 2020 Country:
United States
United States
Employees: N/A City: WARREN
Market Cap: 89.6M IPO Year: N/A
Target Price: $5.00 AVG Volume (30 days): 1.4M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.19 EPS Growth: N/A
52 Week Low/High: $0.38 - $1.92 Next Earning Date: 11-14-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered TVGN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 17 hours ago

AI Recommendation

hold
Model Accuracy: 74.63%
74.63%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: